Natural antimicrobial agent (reuterin) produced by lactobacillus reuteri for sanitization of biological tissues inoculated with pseudomonas aeruginosa

The study was done to evaluate the efficacy of using reuterin produced by Lactobacillus reuteri to sanitize biological tissues. The microorganism tested in the study was Pseudomonas aeruginosa, a common cause of nosocomial biomaterial‐related infections. The inhibitory effect of reuterin on P. aeruginosa for an inoculated tissue was investigated at different conditions of concentration, temperature, and pH. Additionally, the cellular compatibility of the reuterin‐sanitized tissue was evaluated. Glutaraldehyde was employed as a control. It was noted that the minimum inhibitory concentration (MIC, 33.0 ± 2.9 ppm) and minimum bactericidal concentration (MBC, 50.0 ± 0.0 ppm) values of reuterin for P. aeruginosa were significantly lower than their glutaraldehyde counterparts (MIC, 130.0 ± 8.2 ppm and MBC, 180.0 ± 18.3 ppm). This indicated that reuterin was more efficient than glutaraldehyde as an antimicrobial agent. The addition of reuterin on the inoculated tissue led to a reduced viability of P. aeruginosa. The reduction in the P. aeruginosa culture was more pronounced with increasing the concentration of reuterin (0–100 ppm). At increasing temperature (25–45°C), there was an increasing effect of reuterin on its sanitization activity. However, it should be pointed out that the growth of P. aeruginosa in the nutrient broth was also significantly affected by temperature. The sanitization activity of reuterin was more evident with increasing the pH level (pH 6.5–8.5). The cytotoxicity of reuterin was significantly lower than that of glutaraldehyde. Additionally, the cellular compatibility of the reuterin‐sanitized tissue was superior to its glutaraldehyde‐sanitized counterpart. © 2003 Wiley Periodicals, Inc. Biotechnol Bioeng 84: 233–239, 2003.

[1]  H. Sung,et al.  Feasibility study using a natural compound (reuterin) produced by Lactobacillus reuteri in sterilizing and crosslinking biological tissues. , 2002, Journal of biomedical materials research.

[2]  Yen Chang,et al.  Biocompatibility study of biological tissues fixed by a natural compound (reuterin) produced by Lactobacillus reuteri. , 2002, Biomaterials.

[3]  M. Rasch The influence of temperature, salt and pH on the inhibitory effect of reuterin on Escherichia coli. , 2002, International journal of food microbiology.

[4]  P. Stewart,et al.  Modeling biofilm antimicrobial resistance. , 2000, Biotechnology and bioengineering.

[5]  S. Haynie,et al.  Potential of an antibacterial ultraviolet-irradiated nylon film. , 2000, Biotechnology and bioengineering.

[6]  M. Jakobsen,et al.  Application of reuterin produced by Lactobacillus reuteri 12002 for meat decontamination and preservation. , 1999, Journal of food protection.

[7]  H. Sung,et al.  In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. , 1999, Journal of biomaterials science. Polymer edition.

[8]  H. Sung,et al.  Feasibility study of a natural crosslinking reagent for biological tissue fixation. , 1998, Journal of biomedical materials research.

[9]  J. Debevere,et al.  The effect of Reuterin on Listeria monocytogenes and Escherichia coli O157:H7 in milk and cottage cheese. , 1998, Journal of food protection.

[10]  J. Costerton,et al.  Pseudomonas aeruginosa biofilms are more susceptible to ciprofloxacin than to tobramycin. , 1996, International journal of antimicrobial agents.

[11]  Y. Ikada,et al.  In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification. , 1995, Journal of biomedical materials research.

[12]  J. Feijen,et al.  Influence of ethylene oxide gas treatment on the in vitro degradation behavior of dermal sheep collagen. , 1995, Journal of biomedical materials research.

[13]  R. Tu,et al.  Evaluation of Epoxy Ether Fixed Bovine Arterial Grafts for Mutagenic Potential , 1993, ASAIO journal.

[14]  R. Tu,et al.  Evaluation of two epoxy ether compounds for biocompatible potential. , 2008, Artificial organs.

[15]  B. Murray Problems and mechanisms of antimicrobial resistance. , 1989, Infectious disease clinics of North America.

[16]  L. Axelsson,et al.  In VitroStudies on Reuterin Synthesis byLactobacillus reuteri , 1989 .

[17]  W. Dobrogosz,et al.  Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri , 1989, Antimicrobial Agents and Chemotherapy.

[18]  I. Casas,et al.  Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri , 1988, Antimicrobial Agents and Chemotherapy.

[19]  S. D. Bruck,et al.  Radiation sterilization of polymeric implant materials. , 1988, Journal of biomedical materials research.

[20]  Y Noishiki,et al.  Reduction of the antigenicity and immunogenicity of xenografts by a new cross-linking reagent. , 1988, ASAIO transactions.

[21]  T. Kawada,et al.  Resistance to cefsulodin and gentamicin in Pseudomonas aeruginosa strains in five areas of Japan between 1980 and 1983. , 1986, The Journal of antimicrobial chemotherapy.

[22]  Larry L. Hench,et al.  Biomaterials : an interfacial approach , 1982 .

[23]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[24]  R. Trujillo,et al.  Sporostatic and sporocidal properties of aqueous formaldehyde. , 1972, Applied microbiology.